New Frontiers in Psoriatic Disease Research, Part II: Comorbidities and Targeted Therapies.

导出 OA

翻译打印收藏纠错

作者： Di,Yan ^[1] ; Andrew,Blauvelt ^[2] ; Amit K,Dey ^[3] ; Rachel S,Golpanian ^[4] ; Samuel T,Hwang ^[5] ; Nehal N,Mehta ^[3] ; Bridget,Myers ^[6] ; Zhen-Rui,Shi ^[5] ; Gil,Yosipovitch ^[4] ; Stacie,Bell ^[7] ; Wilson,Liao ^[8]

作者单位： The Ronald O. Perelman Department of Dermatology, NYU Langone Medical Center, New York, New York, USA. ^[1] Oregon Medical Research Center, Portland, Oregon, USA. ^[2] Cardiopulmonary Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA. ^[3] Itch Center, Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA. ^[4] Department of Dermatology, UC Davis Medical Center, Sacramento, California. ^[5] Department of Dermatology, University of California San Francisco, San Francisco, California. ^[6] National Psoriasis Foundation, Portland, Oregon, USA. ^[7] Department of Dermatology, University of California San Francisco, San Francisco, California. Electronic address: wilson.liao@ucsf.edu. ^[8]

主题词关节炎, 牛皮癣(Arthritis, Psoriatic);心血管疾病(Cardiovascular Diseases);共病现象(Comorbidity);人类(Humans);分子靶向治疗(Molecular Targeted Therapy);银屑病(Psoriasis)

DOI 10.1016/j.jid.2021.02.743

PMID 33888321

发布时间 2024-08-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交